Co-founder of Recombinant Data Corp (acquired by Deloitte in 2012 and now known as Converge Health), Aaron is a software developer and data warehousing expert who worked in Silicon Valley in the 1980s with Ralph Kimball’s team at Metaphor, developing what would later be called data warehouse systems. In 1999, he began work in healthcare on the Research Patient Data Registry (RPDR) project at Partners Healthcare Systems in Boston. That work led to the development of a data warehouse to support quality improvement reporting at Partners, and Recombinant was born. The company grew rapidly from 2008 to 2012, and was acquired by Deloitte in 2012. Aaron left Deloitte in 2013 and after taking some time off (and starting a 501(c)3 non-profit organization, the Autoimmune Registry, Inc. to foster research on Autoimmune Disease) he formed Prognosis Data to implement data systems to improve patient care and support medical research on new drugs and treatments.
Chris Uhrich develops and supports open source data solutions for the healthcare and life sciences industries. He is an accomplished solutions architect with over 15 years of healthcare and life sciences experience and over 30 years of software engineering experience. He has designed application and data warehouse solutions for academic medical research institutions, accountable care networks, and pharmaceutical clients. Chris was one of the developers of tranSMART, an open source platform for translational medical research, and he has deployed i2b2 at numerous institutions. He is an experienced team leader as well as a hands-on developer.
Mark Golberg joined Prognosis Data because of its unsurpassed expertise and pragmatic approach to improving research and health care delivery models and informatics. He was most recently the CEO | GM of “Project X”, an innovative platform in the elder care space in development by Red Star Ventures in Cambridge, MA.
Mark was also previously the SVP, HC Strategy and Value Based Care at Converge-Health/Recombinant by Deloitte where he developed the firm’s advanced analytics and care coordination, population health solution platform with the NNEACC ACO Collaborative (Dartmouth, MaineHEALTH, Univ. of VT, EMHS). There he also advised medical centers and major insurers in value based care informatics strategy. He has also served as a consultant at ADLittle, Bain & Company, and as the Director of APM's Clinical Operations Practice serving major academic medical centers and multi-specialty group practices including Mayo, UCLA, SUNY and others. Mark’s healthcare operating experience includes roles as: Chief Operating Officer of a $100M physician practice management company, Founder of an innovative hospital chain (IPO 1985) offering both a provider sponsored plan and consumer health record (PCHR), and COO/turnaround leader of a $100M, venture-backed, medical, temporary staffing company. He has also served as the President or CEO of one medical device and two biotech startup companies.
Mark’s past and present, not for profit, advisory roles include: Technical Advisory Group member at CIMIT (Center for Integration of Medicine and Innovative Technology, a Harvard/MIT/Draper Lab Consortium); advisory board member, Gene Partnership Project (Children’s Hospital Boston); MIT enterprise forum panelist/reviewer; and member Dana Farber Cancer Institute’s Basic Science Visiting Committee.
Jeff Green studied computer science and engineering at the University of California, Irvine. He worked for small companies and large corporations over his 35 year career doing database and software application design, healthcare data harmonization and migration, and data analytics. Jeff entered the healthcare field in 2011, joining the Northwest EHR Collaborative, Inc. (NWEHR) as CTO to implement a Health Information Exchange in Montana. His published work on that project has been presented at the American Medical Informatics Association. Since then, Jeff has served as lead consultant on technical projects at Partners Healthcare in Boston (including Mass General Hospital), the University of Washington, and the Mount Sinai Medical Center in New York City. Jeff is an expert in i2b2 and the Shared Health Research Informatics Network (SHRINE) which allows i2b2 systems to interoperate while protecting patient privacy.
Peter Abend is a database developer with 30 years of experience, 10 in healthcare. He has been involved with all aspects of the product development life cycle, including database design and implementation, data integration and reporting. After 20 years working with data in variety of industries including finance and military, he joined his brother Aaron at Recombinant Data in 2011. At Recombinant, he worked on integration of data from multiple EMR source systems into a central data warehouse, allowing the users to get a more complete picture of patient health trends. With a strong understanding and comfort with master data, EMR and i2b2 data storage, Peter is expert at developing ETL processes for migrating data from one system to another and to merge data from different systems. His acute attention is a major asset to the Prognosis team in delivering processes that ensure data integrity, data quality, and data security.
Michael Kamerick has been on the forefront of health information and data technology for over 25 years, and he has many years of experience in the healthcare IT space, as VP of Provider Acquisition for TriNetx, Director of Research Systems and Co-Director of Biomedical Informatics at University of California, and Managing Director at ConvergeHEALTH by Deloitte.
Michael has been a leader in the movement to leverage data from Electronic Medical Record systems to bring insight and intelligence to the business of medicine and medical research. He has participated in multiple national research initiatives, including EDRN, caBIG and the CTSA. I have participated in and led teams that that have built several distributed research networks and have co-authored papers and posters on the subject.
His background includes positions in software development, technical consulting, product management, enterprise consulting, and IT management at UC Berkeley, Sun Microsystems, WebLogic, Ventaso, Watermark Venture Partners, and mVortex Partners.
Michael earned his BSC in computer science from San Francisco State University.
Jack London, PhD, has been engaged for over 40 years in biomedical informatics research and system development in the domains of bioinformatics, medical informatics, and health care information technology. His research focus was originally in bioinformatics, later shifting to radiology PACS development and other clinical informatics projects. These projects became cancer-centric when he moved from the University of Pennsylvania to the Fox Chase Cancer Center, and subsequently Jefferson’s Sidney Kimmel Cancer Center.
Dr. London’s projects in recent years have involved pathology informatics (tissue banking, molecular diagnostics), clinical trials informatics, and research data analytics (warehousing and data mining). He has experience with integrating clinical, biospecimen, genomic, cancer registry, and experimental data to support researchers in hypothesis generation and cohort definition using the i2b2 and tranSMART platforms. This work includes the development of ontologies for biospecimen, cancer registry, and molecular diagnostic (genomic test) data, and the identification of sources for these data.